Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice.

Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice.

Item
http://www.wikidata.org/entity/Q45857922
Taking Gene Therapy into the ClinicEndothelial progenitor cells (EPCs) as gene carrier system for rat model of human gliomaResistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response.Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives.Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers.Gene- and immunotherapy for hepatocellular carcinoma.Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.Inhibition of tumor growth by polyarginine-fused mutant cytosine deaminase.Hypoxia imaging predicts success of hypoxia-induced cytosine deaminase/5-fluorocytosine gene therapy in a murine lung tumor model.Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice.Cancer gene therapy with HSV-tk/GCV system depends on T-cell-mediated immune responses and causes apoptotic death of tumor cells in vivo.Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical consideration.Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma.Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy.
P2860

Cytosine deaminase/5-fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice.

Item
http://www.wikidata.org/entity/Q45857922
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@en
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@nl
type
label
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@en
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@nl
prefLabel
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@en
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Cytosine deaminase/5-fluorocyt ...... but not in athymic nude mice.
@en
P2093
P2860
P304
P31
P356
10.1002/(SICI)1097-0215(19990517)81:4<592::AID-IJC15>3.0.CO;2-I
P433
P478
P577
P698
P921